






















Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Fast, Simple, and Accurate: In Vivo Dosimeter Calibration for HDR/PDR Brachytherapy
Kertzscher Schwencke, Gustavo Adolfo Vladimir; Andersen, Claus E.; Tanderup, K.
Published in:
International Journal of Radiation Oncology, Biology, Physics





Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Kertzscher Schwencke, G. A. V., Andersen, C. E., & Tanderup, K. (2014). Fast, Simple, and Accurate: In Vivo
Dosimeter Calibration for HDR/PDR Brachytherapy. International Journal of Radiation Oncology, Biology,
Physics, 90(1), S742. DOI: 10.1016/j.ijrobp.2014.05.2157
(H&N) plans. A new imaging insert was designed for the phantom to
measure set-up error (rotations and translations) with respect to radiation
isocenter through automated analysis of portal images acquired during the
visit.
Results: Visits were completed at 14 centers with 17 prostate plans created
and tested (5 IMRT and 12 VMAT) and 14 H&N plans from Year 1 re-
delivered. The average diode pass rate for the prostate plans was higher
(96% for 3%/2mm composite analysis) than that of the H&N plans
(92.3%) in Year 1, which reflects the different complexity in these sites.
Mean pass rate for repeat delivery of the first year H&N plans remained the
same but important variations (+/-) were observed at the center level. The
program proved to be a useful tool to evaluate impact of practice and
infrastructure changes as 7 centers re-computed or re-planned the H&N
case to test new practice or equipment. Quantification of phantom set-up
error (n Z 17) showed minimal rotational errors with only one rotational
error greater than 0.5. Translational error was larger, with maximum er-
rors in lateral, vertical and longitudinal directions of 1.7, 1.1 and 2.1 mm
respectively, but means of <0.1, 0.3 and 0.1 mm. There was no relation-
ship between pass-rate and magnitude of set-up error.
Conclusions: The CQA program provides a controlled testing environment
to assess planning and delivery performance for multiple clinical sites on a
variety of planning and delivery platforms. Repeat delivery is a part of the
continuous quality improvement loop to assess changes in quality of
planning or delivery. Design and integration of a new phantom insert in the
program showed that setup errors were small and had limited impact on
centers’ results. Third year development for the CQA program includes a
new clinical site, and introduction of tests to isolate the impact of multileaf
collimator calibration on IMRT performance.
Author Disclosure: A.L. McNiven: None. D.A. Jaffray: None. D.
Letourneau: None.
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PDR Brachytherapy
G. Kertzscher,1 C.E. Andersen,1 and K. Tanderup2; 1Technical University
of Denmark, Centre for Nuclear Technologies, Roskilde, Denmark,
2Aarhus University Hospital, Department of Oncology, Aarhus, Denmark
Purpose/Objective(s): In vivo dosimetry (IVD) during brachytherapy
(BT) provides with an independent verification of the agreement between
planned and delivered treatments. Despite several benefits from real-time
IVD, e.g. efficient detection of treatment errors, widespread use of IVD is
limited due to factors that compromise the simplicity of the implementa-
tion and the dosimetric accuracy. This study presents a fast and accurate
calibration procedure for real-time point dosimeters which substantially
simplifies clinical implementations of cost efficient and accurate IVD.
Materials/Methods: Impractical and time consuming procedures that
involve filling a water tank for dosimeter calibration were avoided by
means of a custom made dry calibration phantom that was composed of a
14x14x4 cm3 base piece and a 13x4x30 cm3 tower piece that weighted 2.1
kg. Parallel 1 cm separated inserts in the tower piece for the dosimeter
probe and the source catheter provided positional accuracy in lateral di-
rections. The inserts were 15 and 19 cm deep such that the BT source
could irradiate at positions below and along the dosimeter probe tip in the
longitudinal direction. The dosimeter was calibrated based on its response
during a single fly-by BT source scan. The positional accuracy in the
longitudinal direction was provided using an iterative algorithm. In each
iteration, a chi-square fit between measured and calculated dose rates was
performed for candidate relative longitudinal source-to-detector distances.
The algorithm updated the longitudinal distance and calibration co-
efficients in each iteration, and corrected for limited scatter conditions of
the calibration phantom, temperature dependence of the detector, and
energy dependence of the detector material with respect to water. The final
calibration coefficients and energy and temperature corrections were used
for fiber-coupled Al2O3:C real-time dosimetry during water phantom
depth-dose measurements and IVD implementations into the BT treatment
workflow.
Results: The calibration was performed in less than 15 minutes including
the time required to setup the calibration, power the computer, and run the
calibration and iterative algorithm. The water phantom dose rate mea-
surements agreed with AAPM TG43 calculations within 2% for source-to-
detector distances between 1.5 and 7.5 cm when energy corrections were
made, and within 5% without energy corrections. The calibration proce-
dure was feasible to implement in the clinical routine.
Conclusions: The calibration procedure allows for robust and accurate
IVD and a time efficient implementation into the clinical routine. The
calibration algorithm corrects for the for energy and temperature depen-
dence of the detector material and can therefore be adapted for any point
dosimeter probe intended for real-time IVD during BT.
Author Disclosure: G. Kertzscher: None. C.E. Andersen: None. K.
Tanderup: None.
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VMAT Head and Neck Treatment Delivery: Benchmarking Accuracy
of Patient DVH Based QA With Radiological Physics Center (RPC)
Head and Neck Phantom Results
R. Varadhan, A. Haven-Smith, S. Yerich, C. Overbeck, B. Garrity,
and S. Way; Minneapolis Radiation Oncology, Minneapolis, MN
Purpose/Objective(s): The purpose of this study is to a) investigate the
accuracy of patient DVH based QA using volumetric measurement guided
dose reconstruction (MGDR) for head & neck Volumetric Modulated Arc
Therapy (VMAT) delivery by benchmarking against RPC Head and Neck
Phantom results, b) investigate the correlation of 3D detector phantom
based QA using local gamma and global gamma results when compared
against patient DVH based QA.
Materials/Methods: The RPC head and neck phantom was planned and
irradiated using 2 arc VMAT delivery method. The results of point doses from
RPC TLDs at eight locations and dose profiles from radiochromic film through
center of primary PTVinside the phantomwere compared against the treatment
planning system (TPS) and the results from the MGDR analysis based on 3D
detector phantom QA. Also the 3D gamma value was calculated using the
MGDR analysis which compares the TPS dose to the predicted dose distri-
bution. Five head and neck patients were planned using VMAT delivery
method and the QAwas performed using both 3D detector phantom based QA
and patient DVH based analysis using MGDR. The correlation between
gamma pass rates using both global and local gamma criteria was compared
against the gamma pass rates using MGDR analysis.
Results: The ratio of MGDR calculated dose to primary and secondary
planning target volume (PTV) compared with both RPC TLD and Eclipse
TPS doses was  1.05. The ratio of estimated cord dose from MGDR
analysis was  1.09 and 1.03 when compared to RPC TLD and TPS doses
respectively. The displacement between calculated dose gradient in the
region between primary PTV and organ at risk (OAR) in all 3 planes from
MGDR was within 3mm and 1mm when compared to RPC film and TPS
profiles respectively. The average 3D local gamma pass rate for the five
clinical cases using MGDR was  97.5% and 92% when using 3% 3mm
and 2% 2mm analysis criteria respectively. The average gamma pass rate
using global gamma 3%3mm criteria was 99.8%, compared to an average
local gamma pass rate of 87.1% using 3D detector phantom based QAwith
a maximum increase of 18%.
Conclusions: Benchmarking the accuracy of patient DVH based QA re-
sults to the RPC head and neck phantom established a baseline accuracy
and confidence in use of MGDR analysis for VMAT delivery in a realistic
patient geometry. For the 5 clinical test cases studied, the low pass rates
obtained using the local gamma evaluation criteria in phantom based QA
had no significant clinical impact for the patient when evaluated using
DVH based QA.
Author Disclosure: R. Varadhan: None. A. Haven-Smith: None. S.
Yerich: None. C. Overbeck: None. B. Garrity: None. S. Way: None.
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